Danish biotech investor Novo Ventures is set for steady deployment this year as it expects companies across the market to raise larger funding rounds in lieu of public listings, senior partner Naveed Siddiqi told Unquote.
LP Profile: Novo Ventures ready for steady deployment amid IPO lull
Most Popular
